Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 1977 Dec;32(6):706–710. doi: 10.1136/thx.32.6.706

Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma

H M Jansen 2, T H The 1, G C De Gast 1, H A Huiges 1, M T Esselink 1, A M Van Der Wal 2, N G M Orie 2
PMCID: PMC470817  PMID: 341406

Abstract

Jansen, H. M., The, T. H., de Gast, G. C., Huiges, H. A., Esselink, M. T., Van der Wal, A. M., and Orie, N. G. M.Thorax, 32, 706-710. Immunoglobulin and complement inclusions in peripheral blood polymorphonuclear leucocytes of patients with bronchial carcinoma. Inclusions in peripheral blood polymorphonuclear leucocytes (PMN) of 23 patients with bronchial carcinoma, of 11 individuals with chronic obstructive lung disease (COLD), and of 11 healthy controls were studied by the indirect immunofluorescence technique for IgG and complement. The relationships of these inclusions to the clinical stage and histology of the malignant disease as well as the influence of subsequent therapy were studied.

Patients with disseminated bronchial carcinoma, stage III, had higher PMN scores than patients with localised disease, stage I. Both patient groups had higher scores than the two control groups. The differences were all statistically significant. There was no difference between the COLD group and the healthy controls.

PMN inclusion scores from the patient group with small- or large-cell undifferentiated carcinoma were higher than from patients with moderately differentiated or well differentiated squamous-cell carcinoma. The first two groups differed significantly from the controls; the latter group did not. Curative surgical therapy gave rise to a significant drop in PMN scores to normal values.

In four patients with regional lymph node metastasis (stage II) the PMN inclusions were related to evidence of recurrence at six months follow-up after operation and BCG immunostimulation.

It is concluded that the PMN inclusions are related to the extent of the disease, to the histological type, and to curative surgical therapy. The possible relation to immune complexes of tumour antigen-antibody origin is discussed.

Full text

PDF
706

Images in this article

707Image
on p.707

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Costanza M. E., Pinn V., Schwartz R. S., Nathanson L. Carcinoembryonic antigen-antibody complexes in a patient with colonic carcinoma and nephrotic syndrome. N Engl J Med. 1973 Sep 6;289(10):520–522. doi: 10.1056/NEJM197309062891007. [DOI] [PubMed] [Google Scholar]
  2. Dixon F. J. Immune complex diseases. J Invest Dermatol. 1972 Dec;59(6):413–415. doi: 10.1111/1523-1747.ep12627589. [DOI] [PubMed] [Google Scholar]
  3. Lewis M. G., Loughridge L. W., Phillips T. M. Immunological studies in nephrotic syndrome associated with extrarenal malignant disease. Lancet. 1971 Jul 17;2(7716):134–135. doi: 10.1016/s0140-6736(71)92305-1. [DOI] [PubMed] [Google Scholar]
  4. Loughridge L. W., Lewis M. G. Nephrotic syndrome in malignant disease of non-renal origin. Lancet. 1971 Feb 6;1(7693):256–258. doi: 10.1016/s0140-6736(71)90999-8. [DOI] [PubMed] [Google Scholar]
  5. Oldstone M. B., Theofilopoulos A. N., Gunvén P., Klein G. Immune complexes associated with neoplasia: presence of Epstein-Barr virus antigen-antibody complexes in Burkitt's lymphoma. Intervirology. 1974;4(5):292–302. doi: 10.1159/000149862. [DOI] [PubMed] [Google Scholar]
  6. Onyewotu I. I., Holborow E. J., Johnson G. D. Detection and radioassay of soluble circulating immune complexes using guinea pig peritoneal exudate cells. Nature. 1974 Mar 8;248(5444):156–159. doi: 10.1038/248156a0. [DOI] [PubMed] [Google Scholar]
  8. Poskitt P. K., Poskitt T. R., Wallace J. H. Renal deposition of soluble immune complexes in mice bearing B-16 melanoma. Characterization of complexes and relationship to tumor progress. J Exp Med. 1974 Aug 1;140(2):410–425. doi: 10.1084/jem.140.2.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sjögren H. O., Hellström I., Bansal S. C., Hellström K. E. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372–1375. doi: 10.1073/pnas.68.6.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Sjögren H. O., Hellström I., Bansal S. C., Warner G. A., Hellström K. E. Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes. Int J Cancer. 1972 Mar 15;9(2):274–283. doi: 10.1002/ijc.2910090205. [DOI] [PubMed] [Google Scholar]
  11. Stühlinger W. D., Verroust P. J., Morel-Maroger L. Detection of circulating soluble immune complexes in patients with various renal diseases. Immunology. 1976 Jan;30(1):43–47. [PMC free article] [PubMed] [Google Scholar]
  12. Theofilopoulos A. N., Wilson C. B., Dixon F. J. The Raji cell radioimmune assay for detecting immune complexes in human sera. J Clin Invest. 1976 Jan;57(1):169–182. doi: 10.1172/JCI108257. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES